Appearance and RF values of samples under UV 365 nm in various fractions. by Asif Khan (1740271)

Subjects:

Effects of <i>B</i>. <i>erecta</i> on motor symptom of PD model rats (Rotarod test). by Asif Khan (1740271)

Subjects:

Clinical and epidemiological characteristics. by Domingos L. S. Rios (20496173)

“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. Conclusion: This study suggests the viability of treating severe obesity by hospitalization with low-calorie diets and immersive lifestyle changes. …”

S1 Data - by Domingos L. S. Rios (20496173)

“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. Conclusion: This study suggests the viability of treating severe obesity by hospitalization with low-calorie diets and immersive lifestyle changes. …”

SI Figure 1- uncropped western blots by Renata Goncalves (15806162)

Subjects:

Age-adjusted incidence rate of gastric cancer over 2000–2019 and in 2020 in the United States, by histologic type. by Armin Aslani (13009188)

Subjects:

Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

Subjects:

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Subjects:

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

Subjects:

Hemodynamic effects of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

Subjects:

<i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats. by Tobias G. Schips (21799838)

Subjects:

Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

Subjects:

Characterization of safety pharmacology of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

FK506 significantly potentiates caspofungin activity against tolerant <i>C. tropicalis</i> strains, reversing tolerance phenotypes in both <i>in vitro</i> and <i>in vivo</i> models... by Yongqin Wu (272012)

“…(F) FK506 substantially decreases the fungal load in <i>G. mellonella</i> larvae infected with tolerant strains and treated with caspofungin. …”

Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke duri... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with Body Weight Support (BWS) for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke dur... by Sanne Ettema (18786312)

Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)